Table 1 Demographics and psychiatric comorbidity of participants

Age (SD)

54 (11)

44 (20)

37 (22)

50 (17)

0.00^a

47 (19)

0.27^b

Gender M

14 (29%)

17 (42%)

9 (33%)

16 (29%)

0.52^c

40 (34%)

0.46^c

Genotype

L_A/L_A

7 (14%)

12 (29%)

12 (44%)

14 (25%)

0.03^c

31 (27%)

0.79^c

S/S

11 (22%)

4 (10%)

5 (19%)

10 (18%)

0.58^c

20 (17%)

0.94^c

L_A/S

25 (51%)

13 (32%)

7 (26%)

21 (38%)

0.16^c

45 (39%)

0.84^c

L_A/L_G

5 (10%)

4 (10%)

2 (7%)

6 (11%)

0.96^c

11 (9%)

0.81^c

S/L_G

1 (2%)

3 (7%)

1 (4%)

4 (7%)

0.54^c

5 (4%)

0.44^c

L_G/L_G

0

1 (2%)

0

0

0.31^c

1 (1%)

0.48^c

CGI (range)

4 (2–7)

3 (1–5)

2 (1–3)

0.00^d

Duration dystonia in years (range)

10 (1–52)

47 (7–73)

23 (1–71)

0.00^d

BDI (range)*

8 (0–28)

8 (0–30)

5 (0–18)

3 (0–19)

0.00^d

8 (0–30)

0.00^e

BAI (range)*

8 (1–31)

8 (0–42)

6 (0–12)

3 (0–21)

0.00^d

7 (0–42)

0.00^e

CDI (range)**

NA

101 (82–126)

88 (73–117)

98 (84–103)

0.28^d

89 (73–126)

0.75^e

SCARED (range)**

NA

4 (1–12)

6 (2–19)

2 (1–24)

0.40^d

4 (1–19)

0.27^e

(C)Y-BOCS (range)

0 (0–12)

0 (0–12)

0 (0–18)

0 (0–9)

0.10^d

0 (0–18)

0.03^e

Psychiatric diagnosis

33 (67%)

24 (59%)

17 (63%)

17 (30%)

0.00^c

74 (63%)

0.00^c

Depressive disorder

16 (33%)

13 (32%)

9 (33%)

8 (14%)

0.09^c

38 (33%)

0.01^c

Anxiety disorder

22 (45%)

20 (49%)

12 (44%)

5 (9%)

0.00^c

54 (46%)

0.00^c